Profile
Shashi Karan worked as a Senior Director & Controller at PathoGenesis Corp from 1992 to 2000.
From 2001 to 2005, he worked as Vice President-Finance at MediaNet Digital, Inc. In 2008, he briefly worked as Secretary & Controller at Cascadian Therapeutics LLC.
Mr. Karan completed his undergraduate degree at the University of Leeds and his graduate degree at Golden Gate University and Long Island University.
Former positions of Shashi Karan
| Companies | Position | End |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Comptroller/Controller/Auditor | 04/10/2010 |
MediaNet Digital, Inc.
 MediaNet Digital, Inc. Specialty TelecommunicationsCommunications MediaNet Digital, Inc. provides digital media fulfillment services. Its services include digital content solutions, content fulfillment services, content information services and integration options and tools. The company was founded in 1999 and is headquartered in Seattle, WA. | Director of Finance/CFO | 31/12/2004 |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Director/Board Member | 31/12/1999 |
Training of Shashi Karan
| University of Leeds | Undergraduate Degree |
| Long Island University | Graduate Degree |
| Golden Gate University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
MediaNet Digital, Inc.
MediaNet Digital, Inc. Specialty TelecommunicationsCommunications MediaNet Digital, Inc. provides digital media fulfillment services. Its services include digital content solutions, content fulfillment services, content information services and integration options and tools. The company was founded in 1999 and is headquartered in Seattle, WA. | Communications |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutic products for the treatment of cancer. Its product ONT-380, is an orally active and selective small-molecule HER2 inhibitor. The firm also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Bothell, WA. | Health Technology |
- Stock Market
- Insiders
- Shashi Karan
